Article

New retinal imaging device in use at Weill Cornell Medical College

The full commercial release and installation of a new retinal imaging device (P200MA, Optos) has been announced at the Weill Cornell Medical College, Department of Ophthalmology, New York.

Marlborough, MA-The full commercial release and installation of a new retinal imaging device (P200MA, Optos) has been announced at the Weill Cornell Medical College, Department of Ophthalmology, New York.

The new device is an imaging platform for use with the optomap fa angiography procedure. The injection of fluorescein in patients allows the physician to capture ultra-wide-field images of fluorescent blood vessels of the patient's retina in real time.

"Clinically, we expect our new device to be very useful in the diagnosis and management of a number of pole to peripheral pathologies, and particularly diabetes by enabling doctors to carry out highly targeted partial pan-retinal photocoagulation-this will allow for new treatment paradigms and improved patient outcomes," said Thomas W. Butts, chief executive officer. "We are very pleased to deliver this device to retinal specialists as it opens new global market segments for us within the medical care segment, of which we estimate a target opportunity of approximately 2.7 million procedures annually in our existing markets in North America and Europe."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
© 2025 MJH Life Sciences

All rights reserved.